Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Post Acute Care Market Size & Share 2026-2035
Report ID: GMI5512
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Post Acute Care Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Post-acute Care Market Size
The post-acute care market was valued at USD 945 billion in 2025, is projected to reach USD 1 trillion in 2026, and is expected to expand at a 6.5% CAGR (2026–2035) to USD 1.77 trillion by 2035.
Post Acute Care Market Key Takeaways
Market Leader: Optum led with over 0.9% market share in 2025.
Leading Players: Top 5 players in this market include Optum, Encompass Health, Ensign Group, Select Medical, VITAS Healthcare, which collectively held a market share of 1.9% in 2025.
The post-acute care market is being reshaped by the interaction of population aging, chronic disease management, and care-delivery models that move clinically appropriate recovery outside acute hospitals. Revenue growth increasingly depends on providers' ability to coordinate transitions, manage patient acuity, and operate across reimbursement arrangements while preserving workforce capacity.
GMI Analyst View
Based on input from industry experts engaged in our primary research process, we expect the global post-acute care market to reach USD 1.29 trillion by 2030. This milestone reflects converging demographic demand and the expanding capacity of technology-enabled home health infrastructure, placing a premium on workforce readiness and coordinated care-delivery networks.
Post-acute Care Market Trends, Growth Drivers & GMI Forecast Outlook
Demographic pressure is broadening demand across recovery settings, while payment discipline and staffing availability determine where that demand can be served. The market's outlook therefore depends less on a single care setting than on providers' ability to shift episodes to clinically appropriate, lower-cost channels without weakening continuity of care.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Aging changes both the number and complexity of post-acute episodes. Stroke recovery, orthopedic intervention, cardiac rehabilitation, dementia-related functional decline, and multi-morbidity often require a sequence of services rather than a single discharge destination. Providers that can coordinate those transitions are better positioned to retain referrals while reducing avoidable acute-care returns.
Home-based models have become a central channel for this demand because they can align patient preference, payer cost management, and continuity of clinical monitoring. Their expansion is not simply a substitution away from facilities: it also enables providers to serve patients whose recovery needs would otherwise be fragmented across hospital discharge, outpatient therapy, and informal caregiving.
Technology is increasingly relevant when it changes operating capability rather than when it merely digitizes documentation. Remote monitoring, predictive discharge tools, and virtual clinical workflows can extend the range of patients managed at home, support earlier intervention when deterioration occurs, and strengthen providers' performance in value-based arrangements.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Prior authorization is most consequential in high-acuity settings where the next level of care requires rapid payer approval after an acute admission. When decisions are delayed or denied, providers can lose not only a referral but also the continuity needed to deliver an effective rehabilitation episode. This creates a portfolio advantage for operators able to offer home health, outpatient rehabilitation, or other alternatives alongside institutional care.
Labor scarcity has a direct revenue consequence because licensed beds and service authorizations do not translate into usable capacity without clinical staff. Institutional operators face fixed facility costs even when units cannot admit patients, while home health agencies must manage travel, scheduling, and retention challenges that are difficult to solve through wage increases alone.
Policy changes intensify the divide between scaled operators and smaller independents. Larger organizations can spread compliance investment, redesign care teams, and support data-intensive reporting across a broader footprint. Smaller facilities may face a sharper choice between investing to meet operational requirements and limiting admissions or seeking a strategic buyer.
GMI Analyst View
We view the forecast period as a test of operating adaptability. Demand is durable, but providers that cannot align staffing, authorization management, and care transitions will struggle to convert that demand into sustainable revenue. Integrated models spanning institutional and community settings should be better insulated from care-site shifts.
Post-acute Care Market Segment Analysis
By Service Setting
Skilled nursing facilities and residential rehabilitation generated USD 388 billion in 2025 within the post-acute care market and are projected to represent 32.4% of market revenue by 2035. The setting remains indispensable for patients requiring nursing intensity, therapy access, or residential support that cannot be safely replicated at home, but its role is becoming more concentrated in higher-complexity episodes as lower-acuity recovery migrates to community channels.
Outpatient rehabilitation generated USD 94 billion in 2025 and is expected to grow at a 7.0% CAGR (2026–2035). This setting benefits from its ability to serve both post-procedure rehabilitation and ongoing chronic-condition management without requiring overnight capacity. Its commercial relevance rises when health systems seek to retain the downstream therapy component of surgical and specialty-care pathways.
Hospice and palliative care is projected to reach USD 98 billion by 2035, while holding a 5.8% share in 2025. Demand is supported by broader recognition that symptom management and goals-of-care planning can improve the patient experience while reducing avoidable acute utilization. Provider differentiation increasingly rests on clinical quality, referral relationships, and the ability to support families across settings.
Inpatient rehabilitation facilities generated USD 55 billion in 2025 and are projected to reach USD 90 billion by 2035. Their multidisciplinary model remains especially relevant for complex neurological, orthopedic, and cardiopulmonary recovery, although payer authorization practices can constrain admissions. Strong outcomes reporting and acute-hospital referral integration are critical to protecting their position.
Long-term acute-care hospitals are projected to reach USD 16 billion by 2035 and grow at a 3.0% CAGR (2026–2035). The segment retains a specialized role for medically complex patients requiring extended, acute-level monitoring, but site-neutral payment policy and tighter qualifying criteria restrict expansion beyond that clinical core.
By Disease / Indication
Neurological disorders generated USD 284 billion in 2025 and are expected to grow at a 7.5% CAGR (2026–2035). Stroke, dementia, Parkinson's disease, and other neurological conditions frequently require care across inpatient rehabilitation, skilled nursing, home health, and outpatient therapy, making the segment particularly valuable to providers that can manage long recovery arcs rather than isolated episodes.
Orthopedic and musculoskeletal indications are projected to reach USD 426 billion by 2035 and accounted for 24.0% of market revenue in 2025. Joint replacement, fracture recovery, spine care, and chronic mobility conditions produce predictable rehabilitation demand, but the mix of care settings depends on surgical complexity, functional status, and the availability of coordinated outpatient and home-based services.
Cardiovascular conditions generated USD 189 billion in 2025 and are projected to hold a 19.1% share by 2035. The segment continues to support demand for home health, skilled nursing, and rehabilitation following cardiac events, although less invasive treatment pathways can reduce post-acute intensity for certain patients. Providers must therefore match care pathways to changing intervention patterns.
Brain injury and spinal cord injury are projected to reach USD 145 billion by 2035 and expand at a 5.5% CAGR (2026–2035). These patients often require longer rehabilitation durations, specialized clinical teams, and coordinated transitions between institutional and community settings. Outcomes capability and specialty referral relationships are more decisive than broad geographic scale alone.
Wound care and complex medical indications represented 7.0% of revenue in 2025 and are projected to reach USD 113 billion by 2035. Diabetes-related complications, chronic wounds, and medically complex recovery create sustained demand for skilled intervention, particularly where providers can combine nursing, equipment management, and coordinated follow-up without unnecessary hospitalization.
Amputations and limb loss generated USD 38 billion in 2025 and are projected to grow at a 5.0% CAGR (2026–2035). Recovery frequently requires prosthetic coordination, gait training, functional adaptation, and support across several settings, creating an advantage for providers with established rehabilitation networks and specialist clinical capabilities.
Other indications are projected to reach USD 101 billion by 2035 and grow at a 6.1% CAGR (2026–2035). Pulmonary rehabilitation, oncology recovery, and multi-morbidity management broaden the addressable need for coordinated post-acute services, particularly as patients survive acute episodes while carrying more complex long-term care requirements.
By Patient Age Group
The elderly population generated USD 680 billion in 2025 and is projected to represent 72.9% of market revenue by 2035. This cohort carries the greatest concentration of chronic disease, functional decline, surgical recovery, and long-term care need. Providers serving this population must balance clinical acuity with payer complexity and caregiver coordination.
Adults aged 18–64 are projected to reach USD 405 billion by 2035 and held a 23.0% share in 2025. Traumatic injuries, working-age neurological conditions, occupational musculoskeletal disorders, and medically complex recovery support demand, while commercial insurance and Medicaid benefit design can materially influence access and service mix.
Pediatric post-acute care generated USD 48 billion in 2025 and is expected to expand at a 4.6% CAGR (2026–2035). Care is highly specialized and often centered on children's hospitals, pediatric skilled nursing, outpatient therapy, and family-led coordination. Growth is shaped by clinical specialization rather than the demographic forces driving adult and elderly care.
GMI Analyst View
We see the central segment shift as a redistribution of recoverable acuity rather than the displacement of institutional care. Home health and outpatient rehabilitation gain where care can be safely decentralized, while skilled nursing, inpatient rehabilitation, and long-term acute care retain defensible roles in clinically complex episodes. Success will depend on matching clinical specialization to the right site of care.
Post-acute Care Market Regional Analysis
North America Post-acute Care Market Analysis
North America generated USD 521 billion in 2025 and is projected to represent 47.4% of market revenue by 2035. The post-acute care market in the region is defined by advanced reimbursement infrastructure, a substantial Medicare and Medicaid funding base, and extensive provider specialization. Its relative share moderation reflects faster development elsewhere rather than a weakening need for post-hospital and chronic-care services.
United States
The United States generated USD 494 billion in 2025 and is projected to grow at a 4.9% CAGR (2026–2035). Medicare payment policy, Medicare Advantage authorization practices, workforce availability, and hospital discharge incentives shape the service-setting mix. Providers with diversified home-based, outpatient, and institutional capabilities are better positioned to manage payer-directed shifts in referrals.
Canada
Canada generated USD 27 billion in 2025 and is projected to reach USD 46 billion by 2035. Provincial investment in home care and integrated pathways is increasing the importance of community-based recovery, while long-term residential care reform continues to influence capacity planning and quality expectations.
Europe Post-acute Care Market Analysis
Europe is projected to reach USD 396 billion by 2035 and grow at a 6.6% CAGR (2026–2035). Established long-term care systems provide a comparatively mature funding base, but aging populations and workforce pressure are forcing national systems to expand home care, intermediate care, and digitally enabled rehabilitation pathways.
Germany
Germany generated USD 68 billion in 2025 and is projected to reach USD 129 billion by 2035. Mandatory long-term care insurance provides an important foundation for both institutional and home-based services, while demographic demand and benefit reforms support continued care-delivery investment.
United Kingdom
The United Kingdom is projected to reach USD 61 billion by 2035 and grow at a 6.7% CAGR (2026–2035). Discharge-to-assess models strengthen the role of community and intermediate care by moving assessment and recovery planning outside acute beds, increasing the importance of coordinated regional referral systems.
France
France generated USD 38 billion in 2025 and is expected to grow at a 6.6% CAGR (2026–2035). The balance between EHPAD-based institutional care and community services creates opportunities for providers that can improve care continuity while meeting expectations for facility modernization and workforce development.
Italy
Italy generated USD 22 billion in 2025 and is projected to reach USD 42 billion by 2035. Aging-related neurological and musculoskeletal needs, combined with investment in community health infrastructure, are expanding the formal post-acute service base alongside longstanding reliance on family caregivers.
Spain
Spain is projected to reach USD 30 billion by 2035 and grow at a 6.5% CAGR (2026–2035). Expansion of long-term care benefits and increasing private participation in residential and rehabilitation services are supporting demand, though regional differences in implementation remain commercially important.
Netherlands
The Netherlands is projected to reach USD 34 billion by 2035 and grow at a 6.6% CAGR (2026–2035). Its established home-care infrastructure and multidisciplinary discharge practices support a service mix that can limit unnecessary institutional stays while maintaining intensive support for patients with complex needs.
Rest of Europe
Other European markets are advancing through a mix of publicly funded home-care expansion, rehabilitation modernization, and initiatives to manage aging-related demand outside acute hospitals. National reimbursement rules and workforce availability remain the principal differentiators.
Asia Pacific Post-acute Care Market Analysis
Asia Pacific accounted for 19.4% of market revenue in 2025 and is projected to reach USD 460 billion by 2035. The region combines highly advanced aging societies with developing formal-care systems, creating both volume growth and execution complexity. Reimbursement development, provider infrastructure, and workforce availability will determine how quickly latent demand converts into formal service utilization.
Japan
Japan generated USD 88 billion in 2025 and is projected to grow at a 6.0% CAGR (2026–2035). Its established long-term care insurance system underpins demand, but labor scarcity makes technology adoption, prevention, and home-based support increasingly important to maintaining care capacity.
China
China is projected to reach USD 104 billion by 2035 and grow at a 14.5% CAGR (2026–2035). Formal post-acute infrastructure remains underdeveloped relative to need, while long-term care insurance pilots and community-rehabilitation investment are establishing a more structured basis for provider expansion.
India
India generated USD 14 billion in 2025 and is projected to grow at a 15.1% CAGR (2026–2035). Urbanization, private insurance growth, chronic disease burden, and underpenetrated formal rehabilitation services create a strong development opportunity, although demand remains concentrated in metropolitan and privately financed care pathways.
South Korea
South Korea is projected to reach USD 43 billion by 2035 and grow at a 9.7% CAGR (2026–2035). Long-term care insurance, a dense rehabilitation-provider base, and strong digital-health adoption support technology-integrated care delivery as the country's demographic profile ages rapidly.
Australia
Australia generated USD 23 billion in 2025 and is projected to reach USD 45 billion by 2035. Aged-care funding reform is strengthening the emphasis on home-based support, while universal coverage and high quality expectations support demand for coordinated recovery and rehabilitation services.
Rest of Asia Pacific
Other Asia Pacific markets are building formal post-acute capacity through private hospital investment, expanding insurance coverage, and community-care development. Market potential is substantial, but provider strategy must account for uneven reimbursement maturity and infrastructure.
Latin America Post-acute Care Market Analysis
Latin America generated USD 19 billion in 2025 and is expected to grow at an 8.2% CAGR (2026–2035). Chronic disease, aging, expanding social coverage, and private investment in rehabilitation infrastructure are increasing demand, although affordability and public-system capacity remain material constraints.
Brazil
Brazil generated USD 8 billion in 2025 and is projected to reach USD 18 billion by 2035. Chronic disease burden and private supplementary coverage support demand for home health, rehabilitation, and skilled services, while provider investment remains concentrated in large urban markets.
Mexico
Mexico generated USD 5.5 billion in 2025 and is projected to grow at an 8.1% CAGR (2026–2035). Diabetes, hypertension, and musculoskeletal conditions underpin rehabilitation need, while the pace of structured post-acute coverage expansion will influence service access and provider economics.
Argentina
Argentina is projected to reach USD 7 billion by 2035 and grow at an 8.8% CAGR (2026–2035). Private insurance coverage and clinic investment support rehabilitation capacity, but economic volatility remains a constraint on capital investment and consumer purchasing power.
Rest of Latin America
Other Latin American markets are expanding through private rehabilitation networks and incremental public-benefit development. Operators must balance long-term demographic opportunity against fragmented payer arrangements and uneven care infrastructure.
Middle East & Africa Post-acute Care Market Analysis
The Middle East & Africa is projected to reach USD 33 billion by 2035 and grow at an 8.9% CAGR (2026–2035). Infrastructure investment, private hospital-network expansion, and rising noncommunicable disease burdens are creating demand for more formal rehabilitation and recovery services, particularly in Gulf markets.
Saudi Arabia
Saudi Arabia generated USD 4.5 billion in 2025 and is projected to reach USD 11 billion by 2035. Healthcare transformation, private-sector participation, and the need to address diabetes, cardiovascular disease, and musculoskeletal conditions are expanding the market for organized post-acute services.
UAE
The UAE is projected to reach USD 7 billion by 2035 and grow at an 8.8% CAGR (2026–2035). Regulatory development, specialist provider entry, and the country's role as a regional medical-services hub are broadening the range of rehabilitation and recovery offerings.
South Africa
South Africa generated USD 2.5 billion in 2025 and is projected to grow at a 9.2% CAGR (2026–2035). Demand from traumatic injury, stroke, and chronic neurological conditions supports rehabilitation investment, while the future breadth of formal coverage remains dependent on health-system implementation.
Rest of MEA
Other markets in the region are developing rehabilitation capacity through private hospital expansion and selective public investment. Service availability remains uneven, leaving local partnerships and regulatory navigation central to market entry.
GMI Analyst View
We expect regional growth to be determined by the interaction of demographic timing and care-system maturity. North America and Europe offer established but operationally demanding markets, whereas Asia Pacific, Latin America, and the Middle East & Africa offer faster expansion alongside reimbursement, infrastructure, and execution risks that require locally tailored delivery models.
Post-acute Care Market Share & Competitive Landscape
The post-acute care market share landscape remains highly fragmented: the five largest measured companies accounted for 2.4% of global revenue in 2025. Fragmentation reflects the local nature of referral networks, public funding relationships, clinical licensing, and labor markets. Scale remains valuable, but it does not eliminate the need for local operating capability and payer credibility.
Optum held a 0.9% share in 2025. Its positioning in at-home and community care gives the organization a differentiated role at the intersection of payer relationships, care coordination, and provider delivery. The integration of home health and hospice assets increases strategic relevance but also heightens scrutiny around vertical integration and network access.
Encompass Health held a 0.6% share in 2025. Its focus on inpatient rehabilitation provides a specialized position in high-acuity recovery, where clinical outcomes, hospital referrals, and disciplined capacity expansion are more important competitive levers than broad service-line diversification.
Ensign Group held a 0.4% share in 2025. Its decentralized skilled-nursing operating model illustrates how local facility leadership can coexist with enterprise-scale compliance, quality, and technology infrastructure. Acquisitions remain an important avenue for scaled operators seeking to improve underperforming facilities and deepen geographic density.
Select Medical maintains exposure to high-acuity institutional care through its specialty-hospital and rehabilitation portfolio, where prior authorization and site-neutral policy remain important headwinds. VITAS Healthcare retains a leading hospice position supported by clinical specialization and established referral relationships. BrightSpring Health, LHC Group, Amedisys, Kindred at Home, and Sunrise Rehab remain relevant to the evolving competitive structure as home-based services, integration activity, and payer-provider relationships reshape local markets.
Recent Industry Developments
PACS Group Acquires 34 Eduro Healthcare Skilled Nursing Facilities. PACS Group announced an agreement to acquire operations of 34 skilled nursing facilities from Eduro Healthcare across six states, encompassing 3,633 skilled nursing beds. The transaction underscores continued consolidation as scaled operators pursue regional density, shared operating infrastructure, and stronger referral-network coverage in a fragmented skilled-nursing sector [5]PACS Group, Inc. "PACS Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah." ir.pacs.com.
PACS Group Announces Florida Market Entry. PACS Group announced agreements to acquire operations of 32 skilled nursing facilities across Florida, comprising 4,049 licensed skilled nursing beds, while confirming additional Eduro facility closings. The expansion illustrates the strategic value of statewide networks in markets where staffing, compliance, and payer relationships increasingly reward operational scale [6]PACS Group, Inc. "PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities." ir.pacs.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →